Bortezomib
- Product NDC
- 70511-161
- 11-digit product format
- 705110161
- Labeler code
- 70511
- Product ID
- 70511-161_2cc294fe-75e3-4ed9-8259-c6e5bc5e8286
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bortezomib
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- MAIA Pharmaceuticals, Inc.
- Application
- NDA215331
- Marketing category
- NDA
- Marketing start
- 2022-08-11
- Substance
- BORTEZOMIB
- Active strength
- 1 mg/1
- Pharmacologic classes
- Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Bortezomib
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BORTEZOMIB | 1 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 69G8BD63PP |
| Rxcui | 2608948, 2608952 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70511-161-05 | Bortezomib | 1 in 1 VIAL, SINGLE-DOSE | INJECTION | 1 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70511-161 | BORTEZOMIB INJECTION [MAIA PHARMACEUTICALS, INC.] | 1 | Current NDC, Legacy NDC, 1 package rows | 20220812_c40e6a28-d577-43d4-bca6-bef28da1d580.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70511-161-05 | 70511016105 | 1 INJECTION in 1 VIAL, SINGLE-DOSE (70511-161-05) | 1 injection | 2022-08-11 | 0000-00-00 | No | No | Current |